Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Year: 2014
Type: article
Source: Circulation
Language: English
Topic: GDF15 and Related Biomarkers
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: growth differentiation factor 15, atrial fibrillation, prognostic factors, apixaban, warfarin, stroke and systemic embolism, major bleeding, mortality, high-sensitivity troponin I, N-terminal pro-brain natriuretic peptide, oxidative stress, inflammation, ARISTOTLE trial, risk stratification, anticoagulation, cardiovascular risk
Open Access status: closed
OpenAlex ID: W2145179900
